Lenvatinib Mesylate Intermediate CAS 205448-65-3 Mimọ> 98.0% (HPLC) Ile-iṣẹ

Apejuwe kukuru:

Orukọ Kemikali: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate

CAS: 205448-65-3

Mimọ:> 98.0% (HPLC)

Irisi: Pa-White to Yellowish Powder

Agbedemeji ti Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Orukọ Kemikali Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate
Awọn itumọ ọrọ sisọ 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Agbedemeji Lenvatinib 3
Nọmba CAS 205448-65-3
NỌMBA CAT RF-PI1973
Iṣura Ipo Ni Iṣura, Agbara iṣelọpọ 50 MT / Ọdun
Ilana molikula C12H11NO4
Òṣuwọn Molikula 233.22
Ojuami farabale 421,0 ± 45,0 ℃
iwuwo 1,267 ± 0,060 g / cm3
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Pa-White to Yellowish Powder
Mimọ / Analysis Ọna > 98.0% (HPLC)
Pipadanu lori Gbigbe <1.00%
Aloku lori Iginisonu <0.50%
Lapapọ Awọn Aimọ <2.00%
H-NMR Ni ibamu si Eto
Igbeyewo Standard Standard Enterprise
Lilo elegbogi Intermediates

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

1

FAQ:

Ohun elo:

Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) jẹ agbedemeji ti Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, ti a ta labẹ orukọ iyasọtọ Lenvima laarin awọn miiran, jẹ oogun egboogi-akàn fun itọju awọn iru kan ti akàn tairodu ati fun awọn aarun miiran bi daradara.O jẹ idagbasoke nipasẹ Eisai Co. ati pe o ṣe bi oludena kinase pupọ si VEGFR1, VEGFR2 ati VEGFR3 kinases.Lenvatinib ti fọwọsi (niwon 2015) fun itọju ti akàn tairodu ti o yatọ ti o jẹ ti agbegbe ti o nwaye tabi metastatic, ilọsiwaju, ati pe ko dahun si itọju pẹlu iodine ipanilara (radioiodine).Ni Oṣu Karun ọdun 2016, Awọn ipinfunni Ounje ati Oògùn AMẸRIKA (FDA) fọwọsi rẹ (ni apapo pẹlu everolimus) fun itọju ti carcinoma sẹẹli kidirin to ti ni ilọsiwaju ti o tẹle ọkan ṣaaju iṣaaju itọju anti-angiogenic.Oogun naa tun fọwọsi ni AMẸRIKA ati ni European Union fun carcinoma hepatocellular ti a ko le yọkuro ni abẹ ni awọn alaisan ti ko gba itọju alakan nipasẹ ẹnu tabi abẹrẹ.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa